Both gain-of-function/dominant negative of FIR (overexpression of FIRΔexon2 in cancer) and loss-of-function of PUF60 (haploinsufficiency in VRJS) contribute to the pathology (Table S1, Figure 5). This evidence concerns the gene PUF60 and cancer.